Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2007 | 07-2006 | 07-2005 | 07-2004 | 07-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,894 | -2,377 | 5,702 | 2,955 | -1,935 |
| Depreciation Amortization | 92 | 47 | 33 | 59 | 188 |
| Accounts receivable | 2,669 | 41 | -3,613 | 484 | 242 |
| Other Working Capital | 965 | -1,755 | -163 | 295 | 177 |
| Other Operating Activity | -270 | 518 | 3,048 | -1,464 | -276 |
| Operating Cash Flow | $-5,437 | $-3,527 | $5,007 | $2,329 | $-1,605 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -228 | -142 | -35 | -10 | -17 |
| Net Acquisitions | N/A | N/A | N/A | 161 | 88 |
| Purchase Of Investment | -750 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -50 |
| Other Investing Activity | 0 | 0 | 838 | 349 | 150 |
| Investing Cash Flow | $-978 | $-142 | $803 | $500 | $222 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 78 | 2,299 | 4,205 | 227 | N/A |
| Other Financing Activity | 0 | 0 | -46 | -250 | 0 |
| Financing Cash Flow | $78 | $2,299 | $4,160 | $-23 | $N/A |
| Beginning Cash Position | 12,909 | 14,280 | 4,310 | 1,504 | 2,887 |
| End Cash Position | 6,572 | 12,909 | 14,280 | 4,310 | 1,504 |
| Net Cash Flow | $-6,337 | $-1,370 | $9,970 | $2,805 | $-1,383 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,437 | -3,527 | 5,007 | 2,329 | -1,605 |
| Capital Expenditure | -228 | -142 | -35 | -10 | -17 |
| Free Cash Flow | -5,666 | -3,669 | 4,972 | 2,319 | -1,621 |